文献速递肝病

治疗性血浆置换改善慢加急性肝衰竭患者短期生存:一项随机对照试验

Therapeutic plasma exchange improves short-term survival in patients with acute-on-chronic liver failure: A randomized controlled trial.
PubMed 文献 · Hepatology · 2026-03-30

这项单中心、开放标签随机对照试验纳入194例慢加急性肝衰竭(ACLF)成人患者,比较标准内科治疗(SMT)联合5次治疗性血浆置换(TPE)与单独SMT的疗效。结果显示TPE组28天死亡率显著低于SMT组(44.3% vs 63.9%,p=0.006),但90天死亡率两组相似;TPE还带来更大的血氨下降和更高的肝衰竭及凝血衰竭缓解率。

要点

  • TPE联合SMT较单独SMT显著降低ACLF患者28天死亡率(44.3% vs 63.9%,p=0.006)。
  • TPE组第7天肝衰竭和凝血衰竭缓解率更高,血氨下降更明显。
  • 两组90天死亡率无显著差异,TPE常见并发症为电解质紊乱和寒战。

核心结论

  • TPE显著改善ACLF患者28天生存率和器官衰竭缓解,但未降低90天死亡率。

研究设计与样本

  • 单中心、开放标签随机对照试验,2022年2月至2025年3月纳入194例18-60岁ACLF(EASL CLIF-C分级1-3b)成人患者,1:1随机分为TPE联合SMT组(n=97)和单独SMT组(n=97)。

主要发现

  • TPE组28天死亡43例(44.3%,95%CI 34.2%-54.8%),SMT组62例(63.9%,95%CI 53.5%-73.4%),p=0.006,绝对风险降低19.6%(95%CI 5.8%-33.3%)。
  • TPE组第7天血氨下降幅度更大,肝衰竭和凝血衰竭缓解率更高。
  • 亚组分析未发现ACLF分级或病因间存在显著异质性。
  • TPE后最常见并发症为电解质紊乱和寒战。

临床怎么用

  • 对于ACLF(EASL CLIF-C分级1-3b)成人患者,可考虑在标准内科治疗基础上加用5次TPE以改善28天生存和器官衰竭缓解。
  • 实施TPE时需监测血流动力学稳定性,并关注电解质紊乱和寒战等并发症。

局限性

  • 单中心、开放标签设计可能引入偏倚。
  • TPE完成率有限(仅57.7%完成全部5次),可能影响疗效评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This randomized controlled trial (RCT) evaluated the efficacy and safety of therapeutic plasma exchange (TPE) versus standard medical therapy (SMT) in acute-on-chronic liver failure (ACLF). APPROACH AND RESULTS: In this single-center, open-label RCT (February 2022-March 2025), we randomly (1:1) assigned 194 adult patients (aged 18-60 y) with ACLF [European Association for the Study of the Liver-Chronic Liver Failure Consortium (EASL CLIF-C) grades 1-3b] to receive SMT plus 5 sessions of TPE (n=97) or SMT alone (n=97). The primary outcome was all-cause mortality at 28 days. Secondary outcomes included 90-day mortality, changes in prognostic scores, resolution of organ failures, infections, and adverse events. Baseline characteristics were comparable between groups. Seventy-two (74.2%) patients completed 3 sessions of TPE, while 56 (57.7%) received all 5 sessions. Hemodynamic instability was the leading cause for discontinuation of TPE (18/41 patients, 43.9%). The 28-day mortality was significantly lower with TPE (43 patients, 44.3%; 95% CI: 34.2%-54.8%) than SMT (62 patients, 63.9%; 95% CI: 53.5%-73.4%), p =0.006; absolute risk reduction: 19.6% (95% CI: 5.8%-33.3%). Ninety-day mortality was similar between groups. TPE resulted in greater reductions in ammonia and higher rates of resolution of hepatic and coagulation failure by day 7 as compared with SMT. Subgroup analysis did not reveal significant heterogeneity across ACLF grade or etiology. Dyselectrolytemia and shivering were the most common complications after TPE. CONCLUSION: TPE significantly improves 28-day survival and organ failure resolution in patients with ACLF, but does not reduce 90-day mortality [CTRI/2022/01/039094].

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Swaroop S, Biswas S, Aggarwal A, et al. Therapeutic plasma exchange improves short-term survival in patients with acute-on-chronic liver failure: A randomized controlled trial. Hepatology. 2026. PMID: 41911559. doi:10.1097/HEP.0000000000001755

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。